|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 35/00 | |||
| A61P 37/06 | |||
| A61K 39/395 | |||
| A61K 39/00 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2709627 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12785624.3 |
| Europos patento paraiškos padavimo data | 2012-05-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/036405 |
| Data | 2012-05-03 |
| (87) | Numeris | WO 2012/158362 |
| Data | 2012-11-22 |
| (30) | Numeris | Data | Šalis |
| 201161486697 P | 2011-05-16 | US |
| (72) |
JOSEPH, Alexandra, US
RICHARDS, Susan, US
RUZEK, Melanie, US
GARMAN, Richard, US
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE |
| INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE |